Our data indicate that TisVed is active against TFhigh IDHwt GBM but not TFlow IDHmut glioma, and that this is mostly due to the antiproliferative and cytotoxic effects of the MMAE conjugate, not the inhibition of TF signaling on the cell surface. This evidence concerns the gene TF and glioblastoma.